Dysfunction of circulating endothelial progenitor cells in major depressive disorder
Ying-Jay Liou1,2, Mu-Hong Chen1,2,3, Ju-Wei Hsu1,2
1Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
Insights
Circulating endothelial progenitor cell (cEPC) adhesive function is reduced in major depressive disorder (MDD), impacting cognitive and psychosocial well-being. Apoptotic function did not significantly differ between patients and controls.
Area of Science:
- Neuroscience
- Cardiovascular Research
- Cell Biology
Background:
- Circulating endothelial progenitor cells (cEPCs) show quantitative alterations in depression.
- No prior studies have examined cEPC functions in major depressive disorder (MDD).
Purpose of the Study:
- To investigate the role of cEPC adhesive and apoptotic functions in MDD.
- To determine if cEPC dysfunction contributes to cognitive and psychosocial impairments in MDD.
Main Methods:
- Recruited 68 MDD patients and 56 healthy controls (HCs).
- Assessed depression, anxiety, psychosomatic symptoms, cognitive function, quality of life, and disability.
- Measured inflammatory markers, cEPC adhesion, and apoptosis using in vitro assays.
Main Results:
- MDD patients exhibited significantly lower cEPC adhesive levels than HCs, independent of inflammatory markers.
- Reduced cEPC adhesion correlated with poorer cognitive performance (2-back, WCST) and increased symptom burden (DSSS, SDS).
- No significant difference in cEPC apoptotic levels was observed between groups.
Conclusions:
- Diminished cEPC adhesive function is a characteristic of MDD.
- This functional deficit in cEPCs is associated with cognitive and psychosocial dysfunction in MDD.
Objectives:
Despite mounting evidence demonstrates circulating endothelial progenitor cells (cEPCs) quantitative changes in depression, no study has investigated cEPC functions in major depressive disorder (MDD). We investigated the role of cEPC adhesive and apoptotic functions in MDD.
Methods:
We recruited 68 patients with MDD and 56 healthy controls (HCs). The depression symptoms, anxiety, psychosomatic symptoms, subjective cognitive dysfunction, quality of life, and functional disability were evaluated using the Hamilton Depression Rating Scale and Montgomery-Åsberg Depression Rating Scale, Hamilton Anxiety Rating Scale, Depression and Somatic Symptoms Scale (DSSS), Perceived Deficits Questionnaire-Depression, 12-Item Short Form Health Survey (SF-12), and Sheehan Disability Scale (SDS), respectively. Working memory and executive function were assessed using a 2-back task and Wisconsin Card Sorting Test (WCST). Inflammatory marker (soluble interleukin-6 receptor, C-reactive protein, and tumor necrosis factor-α receptor-1), cEPC adhesive, and apoptotic levels were measured using in vitro assays.
Results:
The MDD patients showed significantly lower cEPC adhesive levels than the HCs, and this difference in adhesive function remained statistically significant even after adjusting for inflammatory marker levels. The cEPC adhesion levels were in inverse correlations with commission and omission errors in 2-back task, the percent perseverative response and percent perseverative errors in WCST, and the DSSS and SDS scores, but in positive correlations with SF-12 physical and mental component scores. cEPC apoptotic levels did not differ significantly between the groups.
Conclusion:
The findings indicate that cEPC adhesive function is diminished in MDD and impacts various aspects of cognitive and psychosocial functions associated with the disorder.
More Related Videos
Related Concept Videos
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Differentiation of Common Myeloid Progenitor Cells
G-protein Coupled Receptors


